Advertisement

Reactions Weekly

, Volume 1223, Issue 1, pp 3–3 | Cite as

Merck & Co can taranabant for obesity

Media release

Keywords

Public Health Adverse Event Obesity Development Program Clinical Development 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    Merck & Co Inc.Merck Discontinues Development of Investigational Medicine Taranabant for Obesity. Media Release: 3 Oct 2008. Available from: URL: http://www.merck.com

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations